Titoli del Settore Sanitario
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1685 |  GRAL GRAIL, Inc. - Common Stock | 71.96 USD | -3.23% | -5.08% | +17.70% | -27.31% | 3.09 B USD | ||
| 1716 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 30.22 USD | -4.70% | -12.68% | +9.73% | +10.25% | 2.98 B USD | ||
| 1732 |  BEAM Beam Therapeutics Inc. - Common Stock | 28.39 USD | -7.94% | -20.34% | -15.46% | +35.51% | 2.92 B USD | ||
| 1770 |  VERA Vera Therapeutics, Inc. - Class A Common Stock | 39.12 USD | -7.95% | -6.03% | +8.79% | +31.54% | 2.81 B USD | ||
| 1771 |  IRON Disc Medicine, Inc. - Common Stock | 73.47 USD | -3.35% | -6.62% | +2.58% | +25.29% | 2.81 B USD | ||
| 1773 |  SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 48.21 USD | +1.01% | -1.21% | +9.39% | -10.72% | 2.80 B USD | ||
| 1783 |  CLDX Celldex Therapeutics, Inc. - Common Stock | 35.40 USD | -7.60% | -9.00% | +5.08% | +29.96% | 2.78 B USD | ||
| 1785 |  MBX MBX Biosciences, Inc. - Common Stock | 58.32 USD | -3.89% | -10.28% | +36.13% | +346.55% | 2.78 B USD | ||
| 1786 |  XRAY DENTSPLY SIRONA Inc. - Common Stock | 13.85 USD | +3.36% | +16.48% | +36.86% | +5.08% | 2.77 B USD | ||
| 1803 |  ESTA Establishment Labs Holdings Inc. - Common Shares | 92.30 USD | +1.85% | +2.60% | +11.87% | +85.86% | 2.72 B USD | ||
| 1820 |  ATAI AtaiBeckley Inc. - Common Stock | 7.15 USD | +33.40% | +33.64% | +71.88% | +81.01% | 2.63 B USD | ||
| 1821 |  TMDX TransMedics Group, Inc. - Common Stock | 76.00 USD | +0.82% | +5.10% | +0.98% | -33.28% | 2.63 B USD | ||
| 1833 |  KOD Kodiak Sciences Inc - Common Stock | 41.25 USD | -2.76% | +4.11% | +12.09% | +679.77% | 2.58 B USD | ||
| 1836 |  GRDN Guardian Pharmacy Services, Inc. Class A Common Stock | 40.34 USD | +0.98% | -1.32% | -8.07% | +24.70% | 2.55 B USD | ||
| 1846 |  IMNM Immunome, Inc. - Common Stock | 22.20 USD | -3.14% | -8.38% | +18.15% | +111.63% | 2.51 B USD | ||
| 1847 |  ASTH Astrana Health Inc. - Common Stock | 45.10 USD | -4.12% | -4.14% | +15.97% | +80.91% | 2.51 B USD | ||
| 1853 |  PGNY Progyny, Inc. - Common Stock | 31.86 USD | -1.48% | +2.87% | +19.68% | +62.88% | 2.50 B USD | ||
| 1857 |  QURE uniQure N.V. - Ordinary Shares | 39.36 USD | -4.00% | -11.51% | -19.48% | +156.42% | 2.48 B USD | ||
| 1858 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 57.69 USD | +0.33% | -9.49% | -8.25% | -12.67% | 2.48 B USD | ||
| 1862 |  TRVI Trevi Therapeutics, Inc. - Common Stock | 17.36 USD | -4.35% | -5.24% | +2.42% | +151.59% | 2.46 B USD |
Notizie Titoli del Settore Sanitario
ARK di Cathie Wood vende ATAI e acquista azioni X-Energy
Il CMO dell’Oncology Institute Yale Podnos vende azioni per $150k
Il CFO di Gilead Sciences Andrew Dickinson vende azioni per $389.776
Relazione sugli utili: DBV Technologies in calo dopo l’aggiornamento sul Q2 2026
Takeda presenta i risultati dello studio su zasocitinib per la psoriasi
Relazione sugli utili: Intuitive Surgical supera le stime del Q2 2026, il titolo cede
Baker Bros. Advisors LP vende azioni Celcuity per $317,75 mln
Gainers Titoli del Settore Sanitario
 GNPX Genprex, Inc. - Common Stock | 8.00 | +1532.65% |
 SRZNW Surrozen, Inc. - Warrant | 0.0156 | +136.36% |
 LIMNW Liminatus Pharma, Inc. - Warrants | 0.0837 | +67.40% |
 LIMN Liminatus Pharma, Inc. - Class A Common Stock | 0.15 | +36.36% |
 CDNA CareDx, Inc. - Common Stock | 40.34 | +35.60% |
ATAI AtaiBeckley Inc. - Common Stock | 7.15 | +33.40% |
 BIAFW bioAffinity Technologies, Inc. - Warrant | 0.0999 | +23.33% |
 APLM Apollomics Inc. - Class A Ordinary Shares | 23.27 | +21.26% |
Losers Titoli del Settore Sanitario
 WGSWW GeneDx Holdings Corp. - Warrant | 0.0006 | -71.43% |
 DRMAW Dermata Therapeutics, Inc. - Warrant | 0.0080 | -32.20% |
 JAGX Jaguar Health, Inc. - Common Stock | 1.34 | -30.93% |
 VIVS VivoSim Labs, Inc. - Common Stock | 0.61 | -28.24% |
 MODD Modular Medical, Inc. - common stock | 3.24 | -22.67% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.46 | -20.69% |
 ENLV Enlivex Ltd. - Ordinary Shares | 4.75 | -18.66% |
 NXGLW NexGel, Inc - Warrant | 0.0262 | -17.87% |